Julio C. Y. Liu

Julio C. Y. Liu

Auto-generated profile, based on publicly available information

Julio C. Y. Liu

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen 2 , Copenhagen

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JLJulio C Y Liu
Julio C Y Liu
UKUlrike Kühbacher
Ulrike Kühbacher
NLNicolai B Larsen
Nicolai B Larsen
NBNikoline Borgermann
Nikoline Borgermann
DGDimitriya H Garvanska
Dimitriya H Garvanska
NMNiels Mailand
Niels Mailand
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

22 April 2024 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
JLJulio C. Y. Liu
Julio C. Y. Liu
LALeena Ackermann
Leena Ackermann
SHSaskia Hoffmann
Saskia Hoffmann
ZGZita Gál
Zita Gál
IHIvo Alexander Hendriks
Ivo Alexander Hendriks
NMNiels Mailand
Niels Mailand
Protein SUMOylation provides a principal driving force for cellular stress responses, including DNA–protein crosslink (DPC) repair and arsenic-induced PML body degradation. In this study, using genome-scale screens, we identified the human E3 ligase TOPORS as a key effector of SUMO-dependent DPC resolution. We demonstrate that TOPORS promotes DPC repair by functioning as a SUMO-targeted ubiquitin ligase (STUbL), combining ubiquitin ligase activity through its RING domain with poly-SUMO binding via SUMO-interacting motifs, analogous to the STUbL RNF4. Mechanistically, TOPORS is a SUMO1-selective STUbL that complements RNF4 in generating complex ubiquitin landscapes on SUMOylated targets, including DPCs and PML, stimulating efficient p97/VCP unfoldase recruitment and proteasomal degradation. Combined loss of TOPORS and RNF4 is synthetic lethal even in unstressed cells, involving defective clearance of SUMOylated proteins from chromatin accompanied by cell cycle arrest and apoptosis. Our findings establish TOPORS as a STUbL whose parallel action with RNF4 defines a general mechanistic principle in crucial cellular processes governed by direct SUMO–ubiquitin crosstalk.

16 April 2025 in Journal of Cell Biology
Verified
Journal Article
Open access
EJEllis G. Jaffray
Ellis G. Jaffray
MTMichael H. Tatham
Michael H. Tatham
BMBarbara Mojsa
Barbara Mojsa
APAnna Plechanovová
Anna Plechanovová
ARAlejandro Rojas-Fernandez
Alejandro Rojas-Fernandez
RHRonald T. Hay
Ronald T. Hay
Arsenic effectively treats acute promyelocytic leukemia by inducing SUMO and ubiquitin-dependent degradation of the promyelocytic leukemia (PML)–retinoic acid receptor alpha oncogenic fusion protein. However, some patients relapse with arsenic-resistant disease because of missense mutations in PML. To determine the mechanistic basis for arsenic resistance, PML−/− cells were reconstituted with YFP fusions of wild-type PML-V and two common patient mutants: A216T and L217F. Both mutants were resistant to degradation by arsenic but for different biochemical reasons. Arsenic did not trigger SUMOylation of A216T PML, which failed to recruit the SUMO-targeting ubiquitin ligases RNF4 and TOPORS. L217F PML did respond with increased SUMO2/3 conjugation that facilitated RNF4 engagement but failed to reach the threshold of SUMO1 conjugation required to recruit TOPORS. Thus, neither mutant accumulated the appropriate polyubiquitin signal required for p97 binding. These PML mutants have revealed a convergence of SUMO1, SUMO2/3, TOPORS, and RNF4 that facilitates the arsenic-induced degradation of PML.